Abstract
Malaria is one of the priorities of world research in the field of vaccine development, with Plasmodium vivax being the most geographically distributed species in the world and the most prevalent species in the Americas. Unlike Plasmodium falciparum, there is currently no vaccine against P. vivax in advanced clinical trials. Although efforts to design vaccines against P. vivax have been i…